A short term (accelerated release) approach to evaluate peptide release from PLGA depot-formulations.
about
Accelerated dissolution testing for controlled release microspheres using the flow-through dissolution apparatus.Accelerated in-vitro release testing methods for extended-release parenteral dosage forms.FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms.In-vitro dissolution methods for controlled release parenterals and their applicability to drug-eluting stent testing.Recent advances in testing of microsphere drug delivery systems.Polymer degradation and drug delivery in PLGA-based drug-polymer applications: A review of experiments and theories.An Accelerated Release Study to Evaluate Long-Acting Contraceptive Levonorgestrel-Containing in Situ Forming Depot SystemsA short term quality control tool for biodegradable microspheres.In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus.A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres.Development of a dialysis in vitro release method for biodegradable microspheres.FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms.Drug delivery from hydroxyapatite-coated titanium surfaces using biodegradable particle carriers.Aqueous N,N-diethylnicotinamide (DENA) solution as a medium for accelerated release study of paclitaxel.Comparative in vitro release and clinical pharmacokinetics of leuprolide from Luphere 3M Depot, a 3-month release formulation of leuprolide acetate.FIP/AAPS Joint Workshop Report: Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms.Biodegradable thermoresponsive polymeric magnetic nanoparticles: a new drug delivery platform for doxorubicin
P2860
Q33368687-F9F50E3C-86CF-4AB7-BBBB-3C54FADD328DQ36129913-813476E2-5E6F-453A-B17E-98AB9D9418DBQ37360563-F9BAE77F-0155-4F53-88F1-6DCF4FED11F4Q38017707-0F7878F5-537E-4793-9F13-BDBA34667AD4Q38717509-181F23FB-B86E-4E9A-8788-10880A283D3BQ38813199-46A20A8F-DE3D-4B12-A6C4-A10F676D99F3Q39419942-B4872F07-A599-44FF-99AD-D903FB63C2D5Q40027648-6C2724F2-36B0-4060-AE03-9AB2D9513FD9Q41842047-CE986803-1585-42C1-BCF8-6E135BB2646EQ41990221-2ECD7489-AFEA-4E18-AAD4-EB48578DAF6BQ42563947-158FB61D-6516-475F-8037-400F8AFC27D5Q42796672-AA25F3C6-48B6-4DAA-A246-B4F29E2DE145Q44416238-C00F8F7E-0EA6-4CC2-AA3F-7F92F89D0D6FQ44948064-039760A5-2397-4704-A850-0E6C7314F9BEQ47184081-D706E0B1-2ADE-451E-BC3F-62DD9062DA96Q55416890-B9E12044-3E46-49C6-9E8E-9D92CE4238B1Q57355672-7E32FED6-69FC-48C5-922B-EEFF7282B357
P2860
A short term (accelerated release) approach to evaluate peptide release from PLGA depot-formulations.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
A short term (accelerated rele ...... from PLGA depot-formulations.
@en
A short term
@nl
type
label
A short term (accelerated rele ...... from PLGA depot-formulations.
@en
A short term
@nl
prefLabel
A short term (accelerated rele ...... from PLGA depot-formulations.
@en
A short term
@nl
P2093
P2860
P356
P1433
P1476
A short term (accelerated rele ...... from PLGA depot-formulations.
@en
P2093
P2860
P356
10.1208/PS010307
P577
1999-01-01T00:00:00Z